Several hundred people received free blood pressure screenings at different locations throughout the Mount Sinai Health System in May, during National High Blood Pressure Education Month. Regular screenings are an important step in helping to control high blood pressure, which is a leading cause of cardiovascular disease and stroke, but often has no warning signs. Mount Sinai Heart hosted the screenings and distributed educational information at Mount Sinai St. Luke’s, Mount Sinai Beth Israel, The Mount Sinai Hospital, Mount Sinai Beth Israel Brooklyn, and Mount Sinai Queens.
Under blue skies, 80 staff members, families, and friends from the Institute for Advanced Medicine and the Mount Sinai Health System HIV service line participated in the 30th Annual 10K AIDS Walk New York in Central Park on Sunday, May 17.
The Mount Sinai team raised $7,226 to help support HIV/AIDS services, treatment, and research, and joined 40 other tri-state-area AIDS service organizations in the walk. Since its founding, AIDS Walk New York has drawn nearly 890,000 participants and raised more than $139 million.
The Laser Vision Correction Center at New York Eye and Ear Infirmary of Mount Sinai—the first refractive surgery center within the Mount Sinai Health System—recently celebrated its opening. Located at 230 Second Avenue, the new facility offers photorefractive keratectomy, custom LASIK, and IntraLASIK—the first blade-free laser technology that enables physicians to customize vision correction for each patient. Laser vision correction, also known as refractive surgery, treats nearsightedness, farsightedness, and astigmatism, helping to eliminate the need for eyeglasses and contact lenses for many patients. The surgery corrects vision by changing the shape of the cornea, the transparent layer that covers the outer surface of the eye.
A new telehealth initiative run by the Mount Sinai Health System allows patients and their primary care physicians to hold “virtual” appointments or videoconferences for nonurgent follow-up visits. Designed to improve care and enhance convenience, the program can be accessed through an iPhone or Android smartphone app. It is expected to be particularly beneficial for patients with chronic illnesses who require medical management, or those with nonurgent infections—an upper respiratory illness, for example—who require follow-up care. Read more
The Icahn School of Medicine at Mount Sinai has ushered in a new era in digital health care with two pioneering collaborations involving Google [X] Life Sciences (GLS) and Apple Inc.’s recently released ResearchKit framework—software that enables patients to join medical research studies using their iPhones. Read more
The Sinai AppLab, a pioneering digital initiative between the departments of Medicine and Information Technology, is creating technology platforms to address the needs of patients, health care providers, and researchers within the Mount Sinai Health System. Under the direction of Ashish Atreja, MD, MPH, Chief Technology Innovation and Engagement Officer in the Department of Medicine, the lab has developed five apps and an app platform that connect to Mount Sinai’s Electronic Health Records (EHR). Read more
The Mount Sinai Hospital officially opened its 20,700-square-foot Lauder Family Cardiovascular Ambulatory Center with a ribbon-cutting ceremony and reception on Wednesday, May 6, before an audience of jubilant supporters. The expansive Center, which will allow Mount Sinai physicians to treat nearly 300 heart and vascular outpatients a day, was established with generous support from Ronald S. Lauder and Leonard A. Lauder and their families in honor of Valentin Fuster, MD, PhD, the Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital. Read more
The Mount Sinai Health System invited staff, their friends and families, and the public, to learn about skin cancer prevention and receive a free, total-body skin examination during National Skin Cancer Awareness Month in May. The screenings took place in the dermatology departments of The Mount Sinai Hospital, Mount Sinai Beth Israel, Mount Sinai Roosevelt, and, for the first time, at Mount Sinai St. Luke’s. At The Mount Sinai Hospital, 97 people were examined; 81 at Mount Sinai Beth Israel; 77 at Mount Sinai Roosevelt; and 22 at Mount Sinai St. Luke’s.
The Multiple Myeloma Research Foundation (MMRF) and Sundar Jagannath, MD, Director, Multiple Myeloma Program, The Tisch Cancer Institute, Mount Sinai Health System, teamed up recently to host a free patient education symposium at the Sheraton New York. Dr. Jagannath is a renowned researcher and clinician in the treatment of multiple myeloma, a relatively rare cancer of the bone marrow that results from abnormal growth of plasma cells. The MMRF, based in Norwalk, Connecticut, is the world’s No. 1 private funder of multiple myeloma research. The 200 attendees learned about managing the disease and today’s most promising treatment options from leading Mount Sinai clinicians. Participants included Ajai Chari, MD, Director of Clinical Research, Multiple Myeloma Program; and Hearn Jay Cho, MD, Assistant Professor of Medicine (Hematology and Medical Oncology), and Bethann Scarborough, MD, Assistant Professor of Medicine (Geriatrics and Palliative Medicine), at Icahn School of Medicine at Mount Sinai. Mount Sinai’s Multiple Myeloma Program is the largest of its kind in New York City.
The Department of Graduate Medical Education at Mount Sinai Beth Israel held its 13th Annual Resident and Fellow Research Fair on Thursday, May 7. Judges reviewed 100 abstracts covering a wide range of topics and selected three that will receive a prize at the hospital’s graduation ceremony on Wednesday, June 10. Additionally, 10 semifinalists will represent Mount Sinai Beth Israel at the Sixth Annual Icahn School of Medicine at Mount Sinai Consortium for Graduate Medical Education Resident and Fellow Research Day on Friday, June 5. Read more